Healthcare ❯ Pharmaceuticals ❯ Weight Loss Drugs ❯ GLP-1 Medications
Novo says Lilly’s nationwide commercials mislead patients by comparing Lilly’s top doses to lower doses of Novo drugs and has asked a federal court to intervene.
